Trial NCT02429934

View at ClinicalTrials.gov 
Org. Study IDs: IM101-330 SLE Arthritis

Last trial update was posted on 2021-05-13

MeSH Interventions

Abatacept

MeSH Conditions

Arthritis Lupus Erythematosus, Systemic

Other Conditions

Systemic Lupus Erythematosus Arthritis

Stopping Reasons

Response rate in placebo group for primary outcome was 100% on interim analysis.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID